Pharming Group N.V.: Pharming Group Notice of Q3 Results

LEIDEN, Netherlands, Oct. 12, 2022 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) confirms it will announce financial results for the nine months ended September 30, 2022 on Thursday, October 27, 2022.

The Company will host a presentation for analysts at 13:30 CET/07:30 ET on October 27, 2022. Dial-in details for the presentation are detailed below.

Conference call dial-in information
Thursday, October 27, 202213:30 CET/07:30 ET

Please note, the Company will only take questions from dial-in attendees

Dial-in details:
Netherlands (Local) [phone]
United Kingdom [phone]
United Kingdom (Local) [phone]
United States [phone]
United States (Local) [phone]
All other locations [phone]
Access code: 497472
Webcast Link:
https://webcast.openbriefing.com/pharming-q32022/

About Pharming Group N.V.

Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules, biologics, and gene therapies that are in early to late-stage development. Pharming is headquartered in Leiden, Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific.

For more information, visit www.pharming.com or find us on LinkedIn.

For further public information, contact:
Pharming Group, Leiden, The Netherlands
Heather Robertson, Investor Relations & Corporate Communications Manager:
T: [phone]
E: [e-mail]

FTI Consulting, London, UK
Victoria Foster Mitchell/Alex Shaw
T: [phone]

FTI Consulting, USA
Jim Polson
T: [phone]

LifeSpring Life Sciences Communication, Amsterdam, The Netherlands
Leon Melens
T: [phone]
E: [e-mail]

Logo - https://mma.prnewswire.com/media/1778344/Pharming_Group_NV_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/pharming-group-notice-of-q3-results-301646259.html